Say Goodbye to Frequent Injections: FDA Gives Thumbs Up to OCREVUS ZUNOVO for MS Patients!

Roche Announces FDA Approval of OCREVUS ZUNOVO™ for Multiple Sclerosis Treatment Basel, 16 September 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the United States Food and Drug Administration (U.S. FDA) has approved OCREVUS ZUNOVO™ (ocrelizumab & hyaluronidase-ocsq) for the treatment of relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS). Breaking…

Read More

Jim Cramer: Bitcoin is a Winner, But Crypto Community Isn’t Convinced – Time to Cash Out?

Celebrity Endorsements: Jim Cramer’s Support for Bitcoin The Bitcoin Buzz Jim Cramer, the lively and opinionated host of Mad Money, has once again stirred the pot with his recent endorsement of Bitcoin on his “Lightning Round” segment. In a surprising turn of events, Cramer advised a trader to invest in Bitcoin instead of MicroStrategy, a…

Read More

Get Ready to Drop it Like it’s Hot: Treasury Yields Take a Dive in Biggest Weekly Plunge Since Last Year’s Thanksgiving and March Madness!

Market Extra: 10- and 30-year Treasury yields head for biggest weekly drops since last November and March 2020 The Latest Trends in the Bond Market Long-term U.S. Treasury yields are currently on track for their largest weekly declines since March 2020 and last November. This surprising development comes just a mere two weeks after these…

Read More

“Unlocking the Potential: Unity Software Inc. (U) Surpasses Stock Market Expectations – A Must-Read for Investors”

Unity Software Inc. Stocks Soar Unity Software Inc. (U) closed the most recent trading day at $22.18, moving +1.88% from the previous trading session. Unity Software Inc., the popular game development platform, has seen a significant increase in its stock value in the latest trading day. This movement has caught the attention of investors and…

Read More